Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Bullboard (TSXV:SBM)

View:
Post by Crazydanon Jan 24, 2024 10:59am

What the hell

You guys still believe all that bull he is feeding you. Any meaningful discovery would instantly trigger an enormous spike in stock price. You can not kept these type of discovery underground th ...more  
Post by bealerton Jan 24, 2024 10:52am

Terrific Press Release

To a newcomer, this press release sounds like we have a BILLION DOLLAR COMPANY on the go here. I personally can't wait for the excitement to see the stock rise up from the ashes of 11 or 12 cents ...more  
Comment by lscfaon Jan 24, 2024 9:47am

RE:Sirona Lab financing

The product launch may be a year away but financing of SL will be sooner and a catalyst for the stock price. If SL can initially raise $10 million for a 10% stake it values GPM at $100 million.
Comment by Turtle4on Jan 24, 2024 9:44am

RE:Sirona Lab financing

Better than 5% royalties for exclusive license
Post by tylerreddickon Jan 24, 2024 9:34am

Sirona Lab financing

Along with any "private" funds providing future financing for Sirona Labs, the company should do a rights offering for existing shareholders, so we can decide if we want to benefit fully ...more  
Post by nevinvestoron Jan 24, 2024 8:56am

Good Update, who cares about the typo.....

Looks to me like a solid plan in the update, also glad to see that they will keep the majority stake in Sirona Laboratories. Who cares about the typo, they mean 2025 and that is already fast to launch ...more  
Post by tylerreddickon Jan 24, 2024 7:44am

More hurry up and wait

Looks like nothing happening here for another year, if ever. And it looks like the AbbVie "deal" is another flop by Howie. Funny though, how everyone here saw the "2024" blunder ...more  
Comment by moneycollectoron Jan 24, 2024 7:03am

RE:Management

I have to agree again. It's highly embarrassing!  
Post by SleepyHowardon Jan 24, 2024 5:59am

Management

They not even know the year for the launch . This Management is a joke
Comment by PeterGon Jan 24, 2024 3:28am

RE:RE:RE:RE:New Press Release - Sirona Biochem Corporate Update January 2024

It is the typical communication disaster from Sirona. Even the smallest things like correct dates caused hurdles for Sirona!! Unbelievable. 
Comment by Turtle4on Jan 24, 2024 2:31am

RE:RE:RE:New Press Release - Sirona Biochem Corporate Update January 2024

2024 is wrong. They mean 2025. I am sure there will be a correction of the news release.
Comment by Pandoraon Jan 24, 2024 2:28am

RE:RE:New Press Release - Sirona Biochem Corporate Update January 2024

"It is our intention to launch our first consumer product containing GlycoProteMim in both Europe and North America through our subsidiary Sirona Laboratories, then expanding to other markets ...more  
Comment by lscfaon Jan 24, 2024 2:17am

RE:New Press Release - Sirona Biochem Corporate Update January 2024

Sounds like Sirona does not plan on licensing Glycoprotemim to others but rather will manufacture and market its own consumer products.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities